View results for a demographic group: |
Select a different topic: |
View results for a different geographical area: |
Total Respond.^ |
Disabilities** | Physical Health Conditions**** | Cancer | Hypertension, Diabetes and organ failure/disease | Dementia and other Cognitive Impairment Disorders | Mental Illnesses, such as Anxiety or Depression | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
N | % | C.I.(95%) | N | % | C.I.(95%) | N | % | C.I.(95%) | N | % | C.I.(95%) | N | % | C.I.(95%) | N | % | C.I.(95%) | ||
North Carolina | 557 | 116 | 21.6 | 17.7-26.2 | 125 | 19.0 | 15.5-23.0 | 51 | 8.6 | 6.0-12.0 | 143 | 27.7 | 23.2-32.7 | 82 | 15.2 | 11.4-20.0 | 40 | 8.0 | 5.6-11.3 |
Medicaid Region 5 | 145 | 26 | 15.5 | 9.5-24.2 | 36 | 21.9 | 14.9-31.0 | 13 | 9.3 | 4.9-16.8 | *** | *** | *** | 22 | 10.7 | 6.0-18.5 | *** | *** | *** |
*These questions are asked only of caregivers. Subpopulation estimates (e.g. gender) refer to the survey respondent, not to the person for whom they provide care.
**Developmental Disabilities such as Autism, Down’s Syndrome, and Spina Bifida or Disabilities such as eye/vision problem (blindness), hearing problems (deafness), Muscular Sclerosis, spinal cord injury, traumatic brain injury.
****Arthritis/Rheumatism, Asthma, Chronic respiratory conditions such as Emphysema or COPD, Physical health conditions such as stroke, Parkinson’s Disease or Lung Disease/Emphysema.
PLEASE NOTE: Due to changes in the weighting methodology and other factors, results from 2021
are NOT comparable to 2010 and earlier years.
Sub-Group estimates have been suppressed because they do not meet statistical reliability standards.
^Use caution in interpreting cell sizes less than 50, % = Percentage, C.I.(95%) = Confidence Interval (at 95 percent probability level).
Percentages are weighted to population characteristics and therefore cannot be calculated exactly from the numbers in this table.
BRFSS Home | Annual Questionnaires | Technical Notes
This page was generated on 22AUG22.